Published in Proc Natl Acad Sci U S A on July 18, 2000
Osteopontin as a means to cope with environmental insults: regulation of inflammation, tissue remodeling, and cell survival. J Clin Invest (2001) 4.63
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders. Am J Pathol (2004) 3.15
Atorvastatin inhibits hypercholesterolemia-induced cellular proliferation and bone matrix production in the rabbit aortic valve. Circulation (2002) 2.93
Adult mesenchymal stem cells and cell-based tissue engineering. Arthritis Res Ther (2002) 2.63
Hyperphosphatemia-induced nanocrystals upregulate the expression of bone morphogenetic protein-2 and osteopontin genes in mouse smooth muscle cells in vitro. Kidney Int (2010) 2.61
Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60
The mechanism of phosphorus as a cardiovascular risk factor in CKD. J Am Soc Nephrol (2008) 1.99
Differentiation of embryonic mesenchymal cells to odontoblast-like cells by overexpression of dentin matrix protein 1. Proc Natl Acad Sci U S A (2001) 1.85
Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int (2009) 1.77
Importance of phosphorylation for osteopontin regulation of biomineralization. Calcif Tissue Int (2005) 1.75
Hyperphosphatemia of chronic kidney disease. Kidney Int (2008) 1.63
Rebamipide delivered by brushite cement enhances osteoblast and macrophage proliferation. PLoS One (2015) 1.50
Differential variability analysis of gene expression and its application to human diseases. Bioinformatics (2008) 1.46
Dissection of genetic factors modulating fetal growth in cattle indicates a substantial role of the non-SMC condensin I complex, subunit G (NCAPG) gene. Genetics (2009) 1.34
Hypophosphatemia: the common denominator of all rickets. J Bone Miner Metab (2009) 1.22
Role of the progressive ankylosis gene (ank) in cartilage mineralization. Mol Cell Biol (2005) 1.22
Osteoblast autonomous Pi regulation via Pit1 plays a role in bone mineralization. Mol Cell Biol (2007) 1.20
Phosphate is a specific signal for ATDC5 chondrocyte maturation and apoptosis-associated mineralization: possible implication of apoptosis in the regulation of endochondral ossification. J Bone Miner Res (2003) 1.19
Phosphate and pyrophosphate mediate PKA-induced vascular cell calcification. Biochem Biophys Res Commun (2008) 1.15
Physiologic and pathologic functions of the NPP nucleotide pyrophosphatase/phosphodiesterase family focusing on NPP1 in calcification. Purinergic Signal (2006) 1.12
The progressive ankylosis protein regulates cementum apposition and extracellular matrix composition. Cells Tissues Organs (2011) 1.11
Calcium phosphate-bearing matrices induce osteogenic differentiation of stem cells through adenosine signaling. Proc Natl Acad Sci U S A (2014) 1.08
Elevated phosphate activates N-ras and promotes cell transformation and skin tumorigenesis. Cancer Prev Res (Phila) (2010) 1.07
Mesenchymal stem cells as a potent cell source for bone regeneration. Stem Cells Int (2012) 1.06
High dietary inorganic phosphate increases lung tumorigenesis and alters Akt signaling. Am J Respir Crit Care Med (2008) 1.05
Inorganic pyrophosphatase induces type I collagen in osteoblasts. Bone (2009) 1.04
Structural and biochemical modification of a collagen scaffold to selectively enhance MSC tenogenic, chondrogenic, and osteogenic differentiation. Adv Healthc Mater (2014) 1.00
Regulation of vascular smooth muscle cell calcification by extracellular pyrophosphate homeostasis: synergistic modulation by cyclic AMP and hyperphosphatemia. Am J Physiol Cell Physiol (2009) 0.98
Combinatorial screening of osteoblast response to 3D calcium phosphate/poly(ε-caprolactone) scaffolds using gradients and arrays. Biomaterials (2010) 0.98
In vivo overexpression of tissue-nonspecific alkaline phosphatase increases skeletal mineralization and affects the phosphorylation status of osteopontin. J Bone Miner Res (2013) 0.97
Multifunctional role of osteopontin in directing intrafibrillar mineralization of collagen and activation of osteoclasts. Acta Biomater (2013) 0.96
Ectonucleotide pyrophosphatase/phosphodiesterase-1 (ENPP1) protein regulates osteoblast differentiation. J Biol Chem (2011) 0.96
Phosphate sensing. Adv Chronic Kidney Dis (2011) 0.93
Effective combination of aligned nanocomposite nanofibers and human unrestricted somatic stem cells for bone tissue engineering. Acta Pharmacol Sin (2011) 0.91
Phosphate: known and potential roles during development and regeneration of teeth and supporting structures. Birth Defects Res C Embryo Today (2008) 0.90
Extensive induction of important mediators of fibrosis and dystrophic calcification in desmin-deficient cardiomyopathy. Am J Pathol (2002) 0.89
Mechanical strain promotes osteoblast ECM formation and improves its osteoinductive potential. Biomed Eng Online (2012) 0.89
Human adipose-derived cells can serve as a single-cell source for the in vitro cultivation of vascularized bone grafts. J Tissue Eng Regen Med (2012) 0.88
High expression of the Pi-transporter SLC20A1/Pit1 in calcific aortic valve disease promotes mineralization through regulation of Akt-1. PLoS One (2013) 0.87
Nanofiber scaffold gradients for interfacial tissue engineering. J Biomater Appl (2012) 0.87
Immobilization of alkaline phosphatase on microporous nanofibrous fibrin scaffolds for bone tissue engineering. Biomaterials (2009) 0.86
The small molecule PKA-specific cyclic AMP analogue as an inducer of osteoblast-like cells differentiation and mineralization. J Tissue Eng Regen Med (2011) 0.85
Altered TNSALP expression and phosphate regulation contribute to reduced mineralization in mice lacking androgen receptor. Mol Cell Biol (2008) 0.85
Biomineralization of a self-assembled extracellular matrix for bone tissue engineering. Tissue Eng Part A (2009) 0.84
(99m)TC-Methylene diphosphonate uptake at injury site correlates with osteoblast differentiation and mineralization during bone healing in mice. Bone Res (2015) 0.84
Quercetin attenuates warfarin-induced vascular calcification in vitro independently from matrix Gla protein. J Biol Chem (2012) 0.84
Combining technologies to create bioactive hybrid scaffolds for bone tissue engineering. Biomatter (2013) 0.84
The effects of immunomodulation by macrophage subsets on osteogenesis in vitro. Stem Cell Res Ther (2016) 0.83
Periodontitis promotes the proliferation and suppresses the differentiation potential of human periodontal ligament stem cells. Int J Mol Med (2015) 0.82
Effects of transgenic Pit-1 overexpression on calcium phosphate and bone metabolism. J Bone Miner Metab (2009) 0.82
Human umbilical cord blood-derived CD34+ cells reverse osteoporosis in NOD/SCID mice by altering osteoblastic and osteoclastic activities. PLoS One (2012) 0.82
Impact of Phosphorus-Based Food Additives on Bone and Mineral Metabolism. J Clin Endocrinol Metab (2015) 0.82
Bio-active engineered 50 nm silica nanoparticles with bone anabolic activity: therapeutic index, effective concentration, and cytotoxicity profile in vitro. Toxicol In Vitro (2013) 0.82
The Phosphate Source Influences Gene Expression and Quality of Mineralization during In Vitro Osteogenic Differentiation of Human Mesenchymal Stem Cells. PLoS One (2013) 0.81
Osteoblast-like cellular response to dynamic changes in the ionic extracellular environment produced by calcium-deficient hydroxyapatite. J Mater Sci Mater Med (2012) 0.81
The roles of bone morphogenetic proteins and their signaling in the osteogenesis of adipose-derived stem cells. Tissue Eng Part B Rev (2013) 0.80
Hypophosphatasia-associated deficiencies in mineralization and gene expression in cultured dental pulp cells obtained from human teeth. J Endod (2012) 0.80
Proliferative effect and osteoinductive potential of extracellular matrix coated on cell culture plates. Springerplus (2013) 0.80
Vitamin-D receptor agonist calcitriol reduces calcification in vitro through selective upregulation of SLC20A2 but not SLC20A1 or XPR1. Sci Rep (2016) 0.79
Nano-hydroxyapatite modulates osteoblast lineage commitment by stimulation of DNA methylation and regulation of gene expression. Biomaterials (2015) 0.79
Stimulatory effect of low-level laser therapy on root development of rat molars: a preliminary study. Lasers Med Sci (2011) 0.79
Chinese red yeast rice (Monascus purpureus-fermented rice) promotes bone formation. Chin Med (2008) 0.79
Dysregulated gene expression in the primary osteoblasts and osteocytes isolated from hypophosphatemic Hyp mice. PLoS One (2014) 0.79
Osteogenic differentiation and gene expression profile of human dental follicle cells induced by human dental pulp cells. J Mol Histol (2014) 0.79
Response of stem cells from different origins to biphasic calcium phosphate bioceramics. Cell Tissue Res (2015) 0.79
Crystal structures of CaSiO3 polymorphs control growth and osteogenic differentiation of human mesenchymal stem cells on bioceramic surfaces. Biomater Sci (2013) 0.79
Inorganic phosphate induces cancer cell mediated angiogenesis dependent on forkhead box protein C2 (FOXC2) regulated osteopontin expression. Mol Carcinog (2014) 0.78
Bioactivity of periodontal ligament stem cells on sodium titanate coated with graphene oxide. Sci Rep (2016) 0.78
Effects of DLX2 overexpression on the osteogenic differentiation of MC3T3-E1 cells. Exp Ther Med (2015) 0.78
Effect of heat treatment on H2O2/HCl etched pure titanium dental implant: an in vitro study. Med Sci Monit (2012) 0.78
Microbioreactor array screening of Wnt modulators and microenvironmental factors in osteogenic differentiation of mesenchymal progenitor cells. PLoS One (2013) 0.77
Polyphosphates inhibit extracellular matrix mineralization in MC3T3-E1 osteoblast cultures. Bone (2013) 0.77
Tantalum implanted entangled porous titanium promotes surface osseointegration and bone ingrowth. Sci Rep (2016) 0.77
Inhibition of osteoblast mineralization by phosphorylated phage-derived apatite-specific peptide. Biomaterials (2015) 0.76
Integrin-β1, not integrin-β5, mediates osteoblastic differentiation and ECM formation promoted by mechanical tensile strain. Biol Res (2015) 0.76
The fundamental parameters of chitosan in polymer scaffolds affecting osteoblasts (MC3T3-E1). J Mater Sci Mater Med (2008) 0.76
Osteoporosis and cardiovascular disease: lessons from chronic kidney disease. Clin Cases Miner Bone Metab (2008) 0.75
Treatment of hypophosphatasia by muscle-directed expression of bone-targeted alkaline phosphatase via self-complementary AAV8 vector. Mol Ther Methods Clin Dev (2016) 0.75
Bioactive Polymeric Materials for Tissue Repair. J Funct Biomater (2017) 0.75
Titanium phosphate glass microcarriers induce enhanced osteogenic cell proliferation and human mesenchymal stem cell protein expression. J Tissue Eng (2015) 0.75
The effects of tissue-non-specific alkaline phosphatase gene therapy on craniosynostosis and craniofacial morphology in the FGFR2C342Y/+ mouse model of Crouzon craniosynostosis. Orthod Craniofac Res (2015) 0.75
Phosphate-Induced Renal Fibrosis Requires the Prolyl Isomerase Pin1. PLoS One (2016) 0.75
L-carnitine and taurine synergistically inhibit the proliferation and osteoblastic differentiation of vascular smooth muscle cells. Acta Pharmacol Sin (2010) 0.75
Salmon DNA Accelerates Bone Regeneration by Inducing Osteoblast Migration. PLoS One (2017) 0.75
Immunoexpression of IGF1, IGF2, and osteopontin in craniofacial bone repair associated with autogenous grafting in rat models treated with alendronate sodium. Clin Oral Investig (2016) 0.75
Secretory pathway Ca(2+) -ATPases promote in vitro microcalcifications in breast cancer cells. Mol Carcinog (2017) 0.75
Microstructures of Randall's plaques and their interfaces with calcium oxalate monohydrate kidney stones reflect underlying mineral precipitation mechanisms. Urolithiasis (2016) 0.75
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria. J Cell Biol (1983) 5.39
Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc Natl Acad Sci U S A (1986) 5.34
Cell-surface receptors for gibbon ape leukemia virus and amphotropic murine retrovirus are inducible sodium-dependent phosphate symporters. Proc Natl Acad Sci U S A (1994) 4.07
Altered wound healing in mice lacking a functional osteopontin gene (spp1). J Clin Invest (1998) 3.56
Antisera and cDNA probes to human and certain animal model bone matrix noncollagenous proteins. Acta Orthop Scand Suppl (1995) 3.52
Osteopontin--a possible anchor of osteoclasts to bone. Proc Natl Acad Sci U S A (1990) 2.90
Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development. J Bone Miner Res (1992) 2.65
Isolation and characterization of two sialoproteins present only in bone calcified matrix. Biochem J (1985) 2.55
p300 and CBP: partners for life and death. J Cell Physiol (1999) 2.36
Osteopontin expression and function: role in bone remodeling. J Cell Biochem Suppl (1998) 2.20
Osteopontin-hydroxyapatite interactions in vitro: inhibition of hydroxyapatite formation and growth in a gelatin-gel. Bone Miner (1993) 2.16
Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell (1992) 2.00
Identification of a DNA sequence responsible for binding of the 1,25-dihydroxyvitamin D3 receptor and 1,25-dihydroxyvitamin D3 enhancement of mouse secreted phosphoprotein 1 (SPP-1 or osteopontin) gene expression. Proc Natl Acad Sci U S A (1990) 1.99
Relationship between collagen synthesis and expression of the osteoblast phenotype in MC3T3-E1 cells. J Bone Miner Res (1992) 1.98
Effects of ascorbic acid on collagen matrix formation and osteoblast differentiation in murine MC3T3-E1 cells. J Bone Miner Res (1994) 1.98
Calcium and collagen binding properties of osteopontin, bone sialoprotein, and bone acidic glycoprotein-75 from bone. J Biol Chem (1992) 1.74
Secreted phosphoproteins associated with neoplastic transformation: close homology with plasma proteins cleaved during blood coagulation. Cancer Res (1988) 1.71
Recognition of osteopontin and related peptides by an alpha v beta 3 integrin stimulates immediate cell signals in osteoclasts. J Biol Chem (1991) 1.65
Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem (1998) 1.51
Diffuse calcification in human coronary arteries. Association of osteopontin with atherosclerosis. J Clin Invest (1994) 1.50
p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. Mol Cell Biol (1998) 1.47
Molecular and cellular basis of genetic resistance to bacterial infection: the role of the early T-lymphocyte activation-1/osteopontin gene. Crit Rev Immunol (1993) 1.40
Structure and expression of the mRNA encoding urinary stone protein (osteopontin). J Biol Chem (1993) 1.34
Molecular cloning of a tumor promoter-inducible mRNA found in JB6 mouse epidermal cells: induction is stable at high, but not at low, cell densities. J Cell Biochem (1987) 1.32
Activation of the osteopontin promoter by the orphan nuclear receptor estrogen receptor related alpha. Cell Growth Differ (1998) 1.30
Osteopontin-induced modifications of cellular functions. Ann N Y Acad Sci (1995) 1.26
The murine gene encoding secreted phosphoprotein 1 (osteopontin): promoter structure, activity, and induction in vivo by estrogen and progesterone. Gene (1991) 1.24
The inhibitory effect of phosphonates on the formation of calcium phosphate crystals in vitro and on aortic and kidney calcification in vivo. Eur J Clin Invest (1970) 1.18
Ultrastructural immunodetection of osteopontin and osteocalcin as major matrix components of renal calculi. J Bone Miner Res (1995) 1.17
Structure--activity relationship of inhibitors of hydroxyapatite formation. Biochem J (1979) 1.11
Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli. Lab Invest (1993) 1.04
Osteopontin overview. Ann N Y Acad Sci (1995) 1.00
Osteopontin in urinary stone formation. Ann N Y Acad Sci (1995) 1.00
Expression of a newly identified phosphate transporter/retrovirus receptor in human SaOS-2 osteoblast-like cells and its regulation by insulin-like growth factor I. Endocrinology (1997) 0.98
Differences in osteopontin up-regulation between proximal and distal tubules after renal ischemia/reperfusion. Kidney Int (1999) 0.97
Soluble alpha v beta 3-integrin ligands raise [Ca2+]i in rat osteoclasts and mouse-derived osteoclast-like cells. Am J Physiol (1994) 0.95
Calcium-binding properties of osteopontin derived from non-osteogenic sources. J Biochem (1993) 0.95
Molecular and cellular biology of osteopontin Potential role in cardiovascular disease. Trends Cardiovasc Med (2011) 0.87
pRB, p107 and p130 as transcriptional regulators: role in cell growth and differentiation. Prog Cell Cycle Res (1997) 0.86
Insulin-like growth factor I-enhanced renal expression of osteopontin after acute ischemic injury in rats. Endocrinology (1996) 0.81
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand. Nature (1999) 8.23
Multiple functional domains in the adenovirus E1A gene. Cell (1987) 4.22
TGF-beta 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB binding domains. Cell (1990) 3.55
Identification of separate domains in the adenovirus E1A gene for immortalization activity and the activation of virus early genes. Mol Cell Biol (1986) 3.52
Imaging amyloid deposition in Lewy body diseases. Neurology (2008) 3.09
Relief of YY1 transcriptional repression by adenovirus E1A is mediated by E1A-associated protein p300. Genes Dev (1995) 2.93
Identification of specific adenovirus E1A N-terminal residues critical to the binding of cellular proteins and to the control of cell growth. J Virol (1993) 2.92
Adenovirus E1A coding sequences that enable ras and pmt oncogenes to transform cultured primary cells. Mol Cell Biol (1986) 2.70
Domains of the adenovirus E1A protein required for oncogenic activity are also required for dissociation of E2F transcription factor complexes. Genes Dev (1991) 2.40
Different functional domains of the adenovirus E1A gene are involved in regulation of host cell cycle products. Mol Cell Biol (1987) 2.38
Lytic and transforming functions of individual products of the adenovirus E1A gene. J Virol (1986) 2.14
Simian virus 40 large-T antigen expresses a biological activity complementary to the p300-associated transforming function of the adenovirus E1A gene products. Mol Cell Biol (1991) 1.85
p300, and p300-associated proteins, are components of TATA-binding protein (TBP) complexes. Oncogene (1993) 1.76
CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein. Cancer Res (1997) 1.70
Interactions between cell growth-regulating domains in the products of the adenovirus E1A oncogene. Mol Cell Biol (1988) 1.64
Gene array analysis of osteoblast differentiation. Cell Growth Differ (2001) 1.64
The human SWI-SNF complex protein p270 is an ARID family member with non-sequence-specific DNA binding activity. Mol Cell Biol (2000) 1.54
Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification. Mol Cell Biol (1991) 1.52
Relationship between alkaline phosphatase levels, osteopontin expression, and mineralization in differentiating MC3T3-E1 osteoblasts. J Cell Biochem (1998) 1.51
p300/CREB binding protein-related protein p270 is a component of mammalian SWI/SNF complexes. Mol Cell Biol (1998) 1.47
Characterization of monoclonal antibodies raised against p300: both p300 and CBP are present in intracellular TBP complexes. J Virol (1997) 1.45
E1A induces phosphorylation of the retinoblastoma protein independently of direct physical association between the E1A and retinoblastoma products. Mol Cell Biol (1991) 1.41
The spectrum of mutations in TBX3: Genotype/Phenotype relationship in ulnar-mammary syndrome. Am J Hum Genet (1999) 1.41
The pharmacology, metabolism, analysis, and applications of coumarin and coumarin-related compounds. Drug Metab Rev (1990) 1.40
Heterotopic ossification after primary cemented and noncemented total hip arthroplasty in patients with osteoarthritis and rheumatoid arthritis. Can J Surg (1994) 1.40
Promoter-specific trans-activation by the adenovirus E1A12S product involves separate E1A domains. Mol Cell Biol (1992) 1.37
DNA-binding properties of the E1A-associated 300-kilodalton protein. Mol Cell Biol (1992) 1.31
Gambling as a form of dependence. Br J Addict Alcohol Other Drugs (1970) 1.29
Comparison of five methods for the assay of serum gentamicin. Antimicrob Agents Chemother (1981) 1.25
E1A promotes association between p300 and pRB in multimeric complexes required for normal biological activity. J Virol (1995) 1.17
Synthesis of p34, the mammalian homolog of the yeast cdc2+/CDC28 protein kinase, is stimulated during adenovirus-induced proliferation of primary baby rat kidney cells. Oncogene (1988) 1.12
Meningococcal vaccines--present and future. Trans R Soc Trop Med Hyg (1991) 1.11
Application of Epstein-Barr virus (EBV) serology to the diagnosis of North American nasopharyngeal carcinoma. Cancer (1983) 1.06
Meningococcal serogroup B vaccine protection trial and follow-up studies in Chile. The Chilean National Committee for Meningococcal Disease. NIPH Ann (1991) 1.05
Limited impact of total parenteral nutrition on nutritional status during treatment for small cell lung cancer. Cancer Res (1985) 1.04
Relationship between E1A binding to cellular proteins, c-myc activation and S-phase induction. Oncogene (2006) 1.00
The role of specific DNA base damages in the X-ray-induced inactivation of bacteriophage PM2. Mutat Res (1985) 0.99
Repression of a matrix metalloprotease gene by E1A correlates with its ability to bind to cell type-specific transcription factor AP-2. Proc Natl Acad Sci U S A (1996) 0.98
The E1A products of oncogenic adenovirus serotype 12 include amino-terminally modified forms able to bind the retinoblastoma protein but not p300. J Virol (1993) 0.95
Varieties of pathological gambling. Br J Psychiatry (1970) 0.92
Transcriptional regulation of the mouse ferritin H gene. Involvement of p300/CBP adaptor proteins in FER-1 enhancer activity. J Biol Chem (1999) 0.91
Reliability and validity of the grading of heterotopic ossification. J Arthroplasty (1994) 0.90
An inter-regional comparison: fatal crashes in the southeastern and non-southeastern United States: preliminary findings. Accid Anal Prev (1999) 0.89
MDR1 expression is associated with adverse survival in melanoma of the uveal tract. Hum Pathol (1998) 0.88
Relief of pruritus by cholestyramine in chronic liver disease. Isr J Med Sci (1965) 0.87
Transforming growth factor beta 1 (TGF beta 1) reduces cellular levels of p34cdc2, and this effect is abrogated by adenovirus independently of the E1A-associated pRB binding activity. Mol Biol Cell (1992) 0.87
The efficacy of tone-reducing features in orthotics on the gait of children with spastic diplegic cerebral palsy. J Pediatr Orthop (2000) 0.87
A multi-scale approach to colorectal cancer: from a biochemical- interaction signaling-network level, to multi-cellular dynamics of malignant transformation. Interplay with mutations and onco-protein inhibitor drugs. Curr Cancer Drug Targets (2012) 0.85
Early prenatal ultrasound diagnosis of cleidocranial dysplasia. Ultrasound Obstet Gynecol (2000) 0.84
Clinical and social aspects of risk-taking. Proc R Soc Med (1970) 0.84
A new monoclonal antibody, P2A8(6), that specifically recognizes a novel epitope on the multidrug resistance-associated protein 1 (MRP1), but not on MRP2 nor MRP3. Hybrid Hybridomics (2001) 0.84
E1A blocks hyperphosphorylation of p130 and p107 without affecting the phosphorylation status of the retinoblastoma protein. J Virol (2000) 0.83
The contribution of dietary purine over-consumption to hyperpuricosuria in calcium oxalate stone formers. J Chronic Dis (1976) 0.83
Low-dose twice-daily fractionated X-irradiation of ovarian tumor cells in vitro generates drug-resistant cells overexpressing two multidrug resistance-associated proteins, P-glycoprotein and MRP1. Anticancer Drugs (2000) 0.83
Peripheral blood vs. bone marrow for molecular monitoring of BCR-ABL1 levels in chronic myelogenous leukemia, a retrospective analysis in allogeneic bone marrow recipients. Int J Lab Hematol (2009) 0.83
Multiple drug-resistance in variant of a human non-small cell lung carcinoma cell line, DLKP-A. Cytotechnology (1992) 0.83
The multidrug-resistant human lung tumour cell line, DLKP-A10, expresses novel drug accumulation and sequestration systems. Biochem Pharmacol (1997) 0.83
Healing of cancellous bone osteotomy in rabbits--Part I: Regulation of bone volume and the regional acceleratory phenomenon in normal bone. J Orthop Res (1993) 0.83
Current standards and future strategies in immunochemotherapy of non-Hodgkin's lymphoma. J BUON (2011) 0.82
Monoclonal antibody NM11 recognizes a C-terminal epitope shared by p300 and CBP. Hybridoma (1997) 0.81
Healing of cancellous bone osteotomy in rabbits--Part II: Local reversal of arthritis-induced osteopenia after osteotomy. J Orthop Res (1993) 0.81
Effects of tetracyclines on angiogenesis in vitro. Cancer Lett (2000) 0.81
Subchronic toxicity of 4-vinylcyclohexene in rats and mice by inhalation exposure. Fundam Appl Toxicol (1996) 0.80
Dynamic simulations of pathways downstream of ERBB-family, including mutations and treatments: concordance with experimental results. Curr Cancer Drug Targets (2010) 0.80
An assessment of the Report of The Royal Commission on Gambling 1976-1978. Br J Addict Alcohol Other Drugs (1979) 0.80
A potential role for cell cycle control proteins in regulation of the cyclic adenosine 5'-monophosphate-responsive glycoprotein hormone alpha subunit gene. Cell Growth Differ (1996) 0.80
Results of the L5178Y mouse lymphoma assay and the Balb/3t3 cell in vitro transformation assay for eight phthalate esters. J Appl Toxicol (2000) 0.80
I-131 total-body scan: localization of disseminated gastric adenocarcinoma. Case report and survey of the literature. J Nucl Med (1984) 0.80
Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography. J Chromatogr (1987) 0.80
Hereditary C1 esterase deficiency in a Zulu kindred. S Afr Med J (2009) 0.79
Endothelin in the urinary bladder. II. Characterization of endothelin receptor subtypes. J Urol (1992) 0.79
Quality of life in low-income patients with metastatic prostate cancer: divergent and convergent validity of three instruments. Qual Life Res (1999) 0.79
Arthritis not immobilization causes bone loss in the carrageenan injection model of inflammatory arthritis. J Orthop Res (1995) 0.79
Abnormal bone remodelling in inflammatory arthritis. Can J Surg (1998) 0.78
Methylprednisolone acetate does not cause inflammatory changes in the epidural space. Anesthesiology (1990) 0.78
Monoclonal antibodies to human endothelin-1: characterization and utilization in radioimmunoassay and immunocytochemistry. Hybridoma (1992) 0.77
A critical analysis of the use of sialic acid determination in the diagnosis of malignancy. Cancer Lett (1991) 0.77
The effect of intravenous hyperalimentation on the dietary intake of patients with small cell lung cancer. A randomized trial. Cancer (1985) 0.77
A chimeric mouse/human anti-IL-2 receptor antibody with enhanced biological activities. Mol Immunol (1992) 0.77
Diazepam treatment of socially isolated monkeys. Am J Psychiatry (1976) 0.76
Differential regulation of p53-dependent and -independent proliferating cell nuclear antigen gene transcription by 12 S E1A oncoprotein requires CBP. J Biol Chem (1998) 0.76
Chemical industry voluntary test program for phthalate esters: health effects studies. Environ Health Perspect (1986) 0.75
Prolactin and aggression in women with fertility problems. J Obstet Gynaecol (2014) 0.75
Orthopaedic device associated Candidal infection - a retrospective review of patient characteristics and outcome. J Infect (2011) 0.75
Gambling with the nation's health? Majority of secondary school children buy tickets. BMJ (1995) 0.75
Differential effects of a murine and chimeric mouse/human anti-interleukin-2 receptor antibody on human T-cell proliferation. Immunology (1992) 0.75
New fellows of the Acoustical Society of America. J Acoust Soc Am (2000) 0.75
Molecular diagnosis and monitoring of chronic myelogenous leukemia: BCR-Abl and more. J BUON (2010) 0.75
Preliminary immunocytochemical studies of MDR-1 and MDR-3 Pgp expression in B-cell leukaemias. Adv Exp Med Biol (1999) 0.75
Tethered cord in a patient with multiple vertebral segmentation defects: a case report. Bull Hosp Jt Dis (2002) 0.75
The fate of arteriotomy patches of dacron. Angiology (1966) 0.75
Acute soman effects in the juvenile baboon: effects on a match-to-sample discrimination task and on total blood acetylcholinesterase. Pharmacol Biochem Behav (1985) 0.75
Preventing thromboembolism in medical inpatients--time to catch up with the surgeons? S Afr Med J (2008) 0.75